Literature DB >> 11217186

Importance of fatalism in understanding mammography screening in rural elderly women.

R M Mayo1, J R Ureda, V G Parker.   

Abstract

This study examined the relationship between demographic factors and other correlates of fatalism, and assessed the impact of fatalistic beliefs on the participation in breast cancer screening in rural women. The subjects were 220 women aged 50 and over recruited from 6 large rural counties in South Carolina. Data were collected using a demographic questionnaire and the revised Powe Fatalism Inventory. Results show significant associations between fatalism and increased age (p = 0.005), race (p = 0.0001), doctor recommendation (p = .0034) and decreased educational level (p = 0.001). Fatalism was associated with noncompliance with mammography screening in univariate analysis among African-American women (OR = .362; 95% CI: 1.11, 11.8). After adjusting for possible confounders (age, education, and doctor recommendation), fatalism was not significantly associated with noncompliance with screening. These results illustrate age, race, and education may be important predictors of fatalism and that fatalism may be one barrier that has previously gone unmeasured and unchallenged in understanding screening behavior in older women.

Entities:  

Mesh:

Year:  2001        PMID: 11217186     DOI: 10.1300/J074v13n01_05

Source DB:  PubMed          Journal:  J Women Aging        ISSN: 0895-2841


  58 in total

1.  Antecedents and mediators of community connection in African American women with breast cancer.

Authors:  Sue P Heiney; Linda J Hazlett; Sally P Weinrich; Linda M Wells; Swann Arp Adams; Sandra Millon Underwood; Rudolph S Parrish
Journal:  Res Theory Nurs Pract       Date:  2011       Impact factor: 0.688

2.  Do recently diagnosed black breast cancer patients find questions about cancer fatalism acceptable? A preliminary report.

Authors:  Barbara D Powe
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

3.  Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women.

Authors:  Alecia Malin Fair; Debra Wujcik; Jin-Mann Sally Lin; Wei Zheng; Kathleen M Egan; Ana M Grau; Victoria L Champion; Kenneth A Wallston
Journal:  J Health Care Poor Underserved       Date:  2010-02

4.  Breast cancer screening is risky business.

Authors:  René Salazar; Judith M E Walsh
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

5.  Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review.

Authors:  Rebecca J Purc-Stephenson; Kevin M Gorey
Journal:  Prev Med       Date:  2008-01-16       Impact factor: 4.018

6.  Reduced fatalism and increased prevention behavior after two high-profile lung cancer events.

Authors:  David B Portnoy; Corinne R Leach; Annette R Kaufman; Richard P Moser; Catherine M Alfano
Journal:  J Health Commun       Date:  2013-11-25

7.  Perceptions of barriers and facilitators of cancer early detection among low-income minority women in community health centers.

Authors:  Gbenga Ogedegbe; Andrea N Cassells; Christina M Robinson; Katherine DuHamel; Jonathan N Tobin; Carol H Sox; Allen J Dietrich
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

8.  Development and psychometric properties of the 12-item diabetes fatalism scale.

Authors:  Leonard E Egede; Charles Ellis
Journal:  J Gen Intern Med       Date:  2009-11-12       Impact factor: 5.128

9.  Promoting colorectal cancer screening discussion: a randomized controlled trial.

Authors:  Shannon M Christy; Susan M Perkins; Yan Tong; Connie Krier; Victoria L Champion; Celette Sugg Skinner; Jeffrey K Springston; Thomas F Imperiale; Susan M Rawl
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

10.  The Reliability and Validity of Prostate Cancer Fatalism Inventory in Turkish Language.

Authors:  Nihal Gördes Aydoğdu; Cantürk Çapık; Fatma Ersin; Aygul Kissal; Zuhal Bahar
Journal:  J Relig Health       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.